BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 23339300)

  • 21. Small molecules that target protein misfolding.
    Gavrin LK; Denny RA; Saiah E
    J Med Chem; 2012 Dec; 55(24):10823-43. PubMed ID: 23075044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of protein-folding diseases at a glance.
    Valastyan JS; Lindquist S
    Dis Model Mech; 2014 Jan; 7(1):9-14. PubMed ID: 24396149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Small-molecule modulation of cellular chaperones to treat protein misfolding disorders.
    Sloan LA; Fillmore MC; Churcher I
    Curr Opin Drug Discov Devel; 2009 Sep; 12(5):666-81. PubMed ID: 19736625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein folding, misfolding, aggregation and their implications in human diseases: discovering therapeutic ways to amyloid-associated diseases.
    Iram A; Naeem A
    Cell Biochem Biophys; 2014 Sep; 70(1):51-61. PubMed ID: 24639112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo aspects of protein folding and quality control.
    Balchin D; Hayer-Hartl M; Hartl FU
    Science; 2016 Jul; 353(6294):aac4354. PubMed ID: 27365453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Folding and Misfolding of Human Membrane Proteins in Health and Disease: From Single Molecules to Cellular Proteostasis.
    Marinko JT; Huang H; Penn WD; Capra JA; Schlebach JP; Sanders CR
    Chem Rev; 2019 May; 119(9):5537-5606. PubMed ID: 30608666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemical kinetics for drug discovery to combat protein aggregation diseases.
    Arosio P; Vendruscolo M; Dobson CM; Knowles TP
    Trends Pharmacol Sci; 2014 Mar; 35(3):127-35. PubMed ID: 24560688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of endoplasmic reticulum-associated degradation rescues native folding in loss of function protein misfolding diseases.
    Wang F; Song W; Brancati G; Segatori L
    J Biol Chem; 2011 Dec; 286(50):43454-64. PubMed ID: 22006919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological chaperoning: a primer on mechanism and pharmacology.
    Leidenheimer NJ; Ryder KG
    Pharmacol Res; 2014 May; 83():10-9. PubMed ID: 24530489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Misfolding of Proteins.
    Argyrou A
    Adv Exp Med Biol; 2020; 1195():249-254. PubMed ID: 32468483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repair of CFTR folding defects with correctors that function as pharmacological chaperones.
    Loo TW; Clarke DM
    Methods Mol Biol; 2011; 741():23-37. PubMed ID: 21594776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rare ER protein misfolding-mistrafficking disorders: Therapeutic developments.
    Hegde RN; Subramanian A; Pothukuchi P; Parashuraman S; Luini A
    Tissue Cell; 2017 Apr; 49(2 Pt A):175-185. PubMed ID: 28222887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small-molecule structure correctors target abnormal protein structure and function: structure corrector rescue of apolipoprotein E4-associated neuropathology.
    Mahley RW; Huang Y
    J Med Chem; 2012 Nov; 55(21):8997-9008. PubMed ID: 23013167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correcting CFTR folding defects by small-molecule correctors to cure cystic fibrosis.
    Mijnders M; Kleizen B; Braakman I
    Curr Opin Pharmacol; 2017 Jun; 34():83-90. PubMed ID: 29055231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacoperones as Novel Therapeutics for Diverse Protein Conformational Diseases.
    Tao YX; Conn PM
    Physiol Rev; 2018 Apr; 98(2):697-725. PubMed ID: 29442594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic strategies for targeting neurodegenerative protein misfolding disorders.
    Scannevin RH
    Curr Opin Chem Biol; 2018 Jun; 44():66-74. PubMed ID: 29902695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological Chaperones: Beyond Conformational Disorders.
    Leidenheimer NJ
    Handb Exp Pharmacol; 2018; 245():135-153. PubMed ID: 29071508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteostasis: bad news and good news from the endoplasmic reticulum.
    Noack J; Brambilla Pisoni G; Molinari M
    Swiss Med Wkly; 2014; 144():w14001. PubMed ID: 25144910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of misfolding in rare enzymatic deficits and use of pharmacological chaperones as therapeutic approach.
    Pampalone G; Grottelli S; Gatticchi L; Lombardi EM; Bellezza I; Cellini B
    Front Biosci (Landmark Ed); 2021 Dec; 26(12):1627-1642. PubMed ID: 34994177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional rescue of misfolding ABCA3 mutations by small molecular correctors.
    Kinting S; Höppner S; Schindlbeck U; Forstner ME; Harfst J; Wittmann T; Griese M
    Hum Mol Genet; 2018 Mar; 27(6):943-953. PubMed ID: 29325094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.